News & Events about Standard Biotools Inc.
An anonymous reader quotes a report from The New York Times: Millions of Americans have used GoodRx, a drug discount app, to search for lower prices on prescriptions like antidepressants, H.I.V. medications and treatments for sexually transmitted diseases at their local drugstores. But U.S. ...
SOUTH SAN FRANCISCO, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose Unleashing tools to accelerate breakthroughs in human health today announced that it will report fourth quarter and full year 2022 financial results onTuesday, February 14, ...
Continued commercial and strategic execution delivers sequential core revenue growth of 4%9% to $26 million$27 million in Q4 2022 for full year total of approximately $94 million$95 million Business restructuring and SBS program on track to deliver over 20% reduction in operating expenses or more ...
Former Danaher Executive Further Strengthens Senior Management TeamSOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc.(Nasdaq:LAB), driven by a bold purpose Unleashing tools to accelerate breakthroughs in human health today announced the appointment of Betsy Jensen ...
Standard BioTools (NASDAQ:LAB Get Rating) and Singular Genomics Systems (NASDAQ:OMIC Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, ...